Rita J Desai
Examiner (ID: 14900, Phone: (571)272-0684 , Office: P/1625 )
Most Active Art Unit | 1625 |
Art Unit(s) | 1612, 1625 |
Total Applications | 2152 |
Issued Applications | 1290 |
Pending Applications | 146 |
Abandoned Applications | 716 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 14213631
[patent_doc_number] => 20190119200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => TERTIARY AMIDES AND METHOD OF USE
[patent_app_type] => utility
[patent_app_number] => 16/091919
[patent_app_country] => US
[patent_app_date] => 2017-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 93229
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 944
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091919
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/091919 | TERTIARY AMIDES AND METHOD OF USE | Apr 5, 2017 | Abandoned |
Array
(
[id] => 14057821
[patent_doc_number] => 10233194
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-19
[patent_title] => Pyrimidine compounds and pyrimido indole compounds and methods of use
[patent_app_type] => utility
[patent_app_number] => 15/479752
[patent_app_country] => US
[patent_app_date] => 2017-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11852
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15479752
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/479752 | Pyrimidine compounds and pyrimido indole compounds and methods of use | Apr 4, 2017 | Issued |
Array
(
[id] => 15977955
[patent_doc_number] => 10669286
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-02
[patent_title] => Fused pentacyclic imidazole derivatives as modulators of TNF activity
[patent_app_type] => utility
[patent_app_number] => 16/086418
[patent_app_country] => US
[patent_app_date] => 2017-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20841
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 327
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16086418
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/086418 | Fused pentacyclic imidazole derivatives as modulators of TNF activity | Mar 30, 2017 | Issued |
Array
(
[id] => 13182057
[patent_doc_number] => 10106528
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-23
[patent_title] => 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonists
[patent_app_type] => utility
[patent_app_number] => 15/468230
[patent_app_country] => US
[patent_app_date] => 2017-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53495
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15468230
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/468230 | 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonists | Mar 23, 2017 | Issued |
Array
(
[id] => 14171597
[patent_doc_number] => 10259793
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-16
[patent_title] => 2-aminopyrimidine derivatives for the treatment of viral infections
[patent_app_type] => utility
[patent_app_number] => 15/464050
[patent_app_country] => US
[patent_app_date] => 2017-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3649
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15464050
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/464050 | 2-aminopyrimidine derivatives for the treatment of viral infections | Mar 19, 2017 | Issued |
Array
(
[id] => 11727968
[patent_doc_number] => 20170189410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-06
[patent_title] => 'Amino Compounds for Treatment of Complement Mediated Disorders'
[patent_app_type] => utility
[patent_app_number] => 15/463701
[patent_app_country] => US
[patent_app_date] => 2017-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39180
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15463701
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/463701 | Amino compounds for treatment of complement mediated disorders | Mar 19, 2017 | Issued |
Array
(
[id] => 16229372
[patent_doc_number] => 10736902
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-11
[patent_title] => Method of treating triple negative breast cancer
[patent_app_type] => utility
[patent_app_number] => 16/085294
[patent_app_country] => US
[patent_app_date] => 2017-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 16
[patent_no_of_words] => 9639
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085294
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/085294 | Method of treating triple negative breast cancer | Mar 16, 2017 | Issued |
Array
(
[id] => 14230325
[patent_doc_number] => 20190127335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => AURORA KINASE AND JANUS KINASE INHIBITORS FOR PREVENTION OF GRAFT VERSUS HOST DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/083681
[patent_app_country] => US
[patent_app_date] => 2017-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23235
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16083681
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/083681 | Aurora kinase and Janus kinase inhibitors for prevention of graft versus host disease | Mar 12, 2017 | Issued |
Array
(
[id] => 16519443
[patent_doc_number] => 10870652
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-22
[patent_title] => Compounds and methods for modulating bruton's tyrosine kinase
[patent_app_type] => utility
[patent_app_number] => 16/083409
[patent_app_country] => US
[patent_app_date] => 2017-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 96676
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 895
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16083409
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/083409 | Compounds and methods for modulating bruton's tyrosine kinase | Mar 9, 2017 | Issued |
Array
(
[id] => 11942018
[patent_doc_number] => 20170246167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => '2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES'
[patent_app_type] => utility
[patent_app_number] => 15/443145
[patent_app_country] => US
[patent_app_date] => 2017-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 243655
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15443145
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/443145 | 2,4-pyrimidinediamine compounds and their uses | Feb 26, 2017 | Issued |
Array
(
[id] => 18273678
[patent_doc_number] => 11612599
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-28
[patent_title] => Glycosidase inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/078159
[patent_app_country] => US
[patent_app_date] => 2017-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58998
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 668
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16078159
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/078159 | Glycosidase inhibitors | Feb 23, 2017 | Issued |
Array
(
[id] => 15290571
[patent_doc_number] => 20190388421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS
[patent_app_type] => utility
[patent_app_number] => 16/081797
[patent_app_country] => US
[patent_app_date] => 2017-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51446
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 831
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16081797
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/081797 | NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS | Feb 22, 2017 | Abandoned |
Array
(
[id] => 14198909
[patent_doc_number] => 10266548
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-23
[patent_title] => Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases
[patent_app_type] => utility
[patent_app_number] => 15/438254
[patent_app_country] => US
[patent_app_date] => 2017-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49002
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 317
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15438254
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/438254 | Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases | Feb 20, 2017 | Issued |
Array
(
[id] => 14993601
[patent_doc_number] => 20190315758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => COMPOUND USED AS BRUTON'S TYROSINE KINASE INHIBITOR AND PREPARATION METHOD AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/468658
[patent_app_country] => US
[patent_app_date] => 2017-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23956
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16468658
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/468658 | Compound used as Bruton's tyrosine kinase inhibitor and preparation method and application thereof | Feb 19, 2017 | Issued |
Array
(
[id] => 11820511
[patent_doc_number] => 20170209449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'PYRROLOPYRIMIDINE DERIVATIVES AS NR2B NMDA RECEPTOR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 15/428321
[patent_app_country] => US
[patent_app_date] => 2017-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 52446
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15428321
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/428321 | Pyrrolopyrimidine derivatives as NR2B NMDA receptor antagonists | Feb 8, 2017 | Issued |
Array
(
[id] => 13901731
[patent_doc_number] => 20190040070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => PROCESS FOR THE SYNTHESIS OF STABLE AMORPHOUS IBRUTINIB
[patent_app_type] => utility
[patent_app_number] => 16/073897
[patent_app_country] => US
[patent_app_date] => 2017-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6677
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073897
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/073897 | PROCESS FOR THE SYNTHESIS OF STABLE AMORPHOUS IBRUTINIB | Feb 7, 2017 | Abandoned |
Array
(
[id] => 13928965
[patent_doc_number] => 20190047998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => NITROGEN-CONTAINING HETEROCYCLE AND CARBOCYCLE DERIVATIVES HAVING TRKA INHIBITORY ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 16/075409
[patent_app_country] => US
[patent_app_date] => 2017-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30096
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16075409
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/075409 | Nitrogen-containing heterocycle and carbocycle derivatives having TrkA inhibitory activity | Feb 2, 2017 | Issued |
Array
(
[id] => 13901699
[patent_doc_number] => 20190040054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => SOLID STATE FORMS OF DASATINIB AND PROCESSES FOR THEIR PREPARATION
[patent_app_type] => utility
[patent_app_number] => 16/073963
[patent_app_country] => US
[patent_app_date] => 2017-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3107
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073963
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/073963 | Solid state forms of dasatinib and processes for their preparation | Feb 2, 2017 | Issued |
Array
(
[id] => 12448329
[patent_doc_number] => 09981961
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-29
[patent_title] => Deoxycytidine kinase inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/421258
[patent_app_country] => US
[patent_app_date] => 2017-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 116
[patent_no_of_words] => 63580
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 474
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15421258
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/421258 | Deoxycytidine kinase inhibitors | Jan 30, 2017 | Issued |
Array
(
[id] => 12023620
[patent_doc_number] => 20170313717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-02
[patent_title] => 'NOVEL GLP-1 RECEPTOR MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 15/416758
[patent_app_country] => US
[patent_app_date] => 2017-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73390
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15416758
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/416758 | GLP-1 receptor modulators | Jan 25, 2017 | Issued |